Yellowbrick Provides Access to Cloud Data Warehouse for COVID-19 Vaccine Research

Yellowbrick is providing free access to its cloud data warehouse to give real-time access and insights of critical data to researchers and companies actively working on a vaccine for COVID-19. 

“We’re proud to offer access to Yellowbrick’s analytics capabilities to researchers who are working tirelessly to make a difference,” said Neil Carson, CEO, Yellowbrick. “We think our innovative technology can give them a powerful boost and help speed the time to insight.”

Virtusa, a digital strategy and services company, has partnered with Yellowbrick to provide implementation consulting and access for its Life Sciences platform, vLifeTM.

Companies actively working on vaccines will have the ability to connect data from a broad range of clinical, drug development, and media sources generating large amounts of daily data into an analytic platform designed for delivering time-critical insights.  

“By joining the capabilities of Virtusa and Yellowbrick, we can help customers provide real-time ingestion, faster performance, and powerful analytics,” said Anthony Lange, SVP, healthcare & life science, Virtusa. “Synthetic data sets available in vLifeTM significantly accelerate research and clinical trials to reduce the timeline for finding and delivering life saving drug therapies.”

For more information about this news, visit